Thursday, February 21, 2019 10:56:59 PM
Thanks for your inquiry. Yes you are correct, and at this time we are struggling with simply keeping the current business plan funded. We have not been able to attract sufficient venture capital to cover current G&A expenses let alone furthering clinical trials and product development. We have done extensive broker roadshows via Renmark for two years and have used other methods to identify sources of capital and to find investors willing to back the company. In our last fiscal year this amounted to dozens of presentations in cities all over Canada and the US that were attended by over 300 brokers. Over the last six months, insiders have loaned the company over $300,000 until proper financing could be put into place. The lack of outside investor interest is forcing us to look at any all options from selling the technology to pursuing joint ventures. If you have any leads for us to consider please do send them along.
Eric
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM